Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Daniel Rubio is active.

Publication


Featured researches published by Daniel Rubio.


PLOS Pathogens | 2012

Antibody Inhibition of a Viral Type 1 Interferon Decoy Receptor Cures a Viral Disease by Restoring Interferon Signaling in the Liver

Ren-Huan Xu; Daniel Rubio; Felicia Roscoe; Tracy E. Krouse; M.E. Truckenmiller; Christopher C. Norbury; Paul N. Hudson; Inger K. Damon; Antonio Alcami; Luis J. Sigal

Type 1 interferons (T1-IFNs) play a major role in antiviral defense, but when or how they protect during infections that spread through the lympho-hematogenous route is not known. Orthopoxviruses, including those that produce smallpox and mousepox, spread lympho-hematogenously. They also encode a decoy receptor for T1-IFN, the T1-IFN binding protein (T1-IFNbp), which is essential for virulence. We demonstrate that during mousepox, T1-IFNs protect the liver locally rather than systemically, and that the T1-IFNbp attaches to uninfected cells surrounding infected foci in the liver and the spleen to impair their ability to receive T1-IFN signaling, thus facilitating virus spread. Remarkably, this process can be reversed and mousepox cured late in infection by treating with antibodies that block the biological function of the T1-IFNbp. Thus, our findings provide insights on how T1-IFNs function and are evaded during a viral infection in vivo, and unveil a novel mechanism for antibody-mediated antiviral therapy.


Journal of Virology | 2012

Memory CD8+ T Cells Specific for a Single Immunodominant or Subdominant Determinant Induced by Peptide-Dendritic Cell Immunization Protect from an Acute Lethal Viral Disease

Sanda Remakus; Daniel Rubio; Xueying Ma; Alessandro Sette; Luis J. Sigal

ABSTRACT The antigens recognized by individual CD8+ T cells are small peptides bound to major histocompatibility complex (MHC) class I molecules. The CD8+ T cell response to a virus is restricted to several peptides, and the magnitudes of the effector as well as memory phases of the response to the individual peptides are generally hierarchical. The peptide eliciting a stronger response is called immunodominant (ID), and those with smaller-magnitude responses are termed subdominant (SD). The relative importance of ID and SD determinants in protective immunity remains to be fully elucidated. We previously showed that multispecific memory CD8+ T cells can protect susceptible mice from mousepox, an acute lethal viral disease. It remained unknown, however, whether CD8+ T cells specific for single ID or SD peptides could be protective. Here, we demonstrate that immunization with dendritic cells pulsed with ID and some but not all SD peptides induces memory CD8+ T cells that are fully capable of protecting susceptible mice from mousepox. Additionally, while natural killer (NK) cells are essential for the natural resistance of nonimmune C57BL/6 (B6) to mousepox, we show that memory CD8+ T cells of single specificity also protect B6 mice depleted of NK cells. This suggests it is feasible to produce effective antiviral CD8+ T cell vaccines using single CD8+ T cell determinants and that NK cells are no longer essential when memory CD8+ T cells are present.


Journal of Virology | 2003

Polyprotein processing protease of African swine fever virus: purification and biochemical characterization.

Daniel Rubio; Alí Alejo; Irene Rodríguez; María L. Salas

ABSTRACT The purified recombinant African swine fever virus polyprotein processing protease cleaves the two GG-X sites in polyprotein pp62 with the same efficiency. Cleavage at the site that is first recognized in vivo is not a requisite for cleavage at the second site, suggesting the existence of mechanisms that control the ordered processing of the polyprotein during infection.


Cell Host & Microbe | 2013

Memory CD8+ T cells can outsource IFN-γ production but not cytolytic killing for antiviral protection

Sanda Remakus; Daniel Rubio; Avital Lev; Xueying Ma; Min Fang; Ren-Huan Xu; Luis J. Sigal

Immunization with vaccinia virus (VACV), the virus comprising the smallpox vaccine, induces memory CD8(+) T cells that protect from subsequent infections with smallpox in humans or the related ectromelia virus (ECTV) in mice. Memory CD8(+) T cells largely mediate these effects by expanding into secondary effectors that secrete the antiviral cytokine interferon-γ (IFN-γ) and induce cytolysis via releasing factors such as perforin, which permeabilizes target cells. We show that protection from ECTV infection after VACV immunization depends on the initial memory cell frequency and ability of expanded secondary effectors to kill infected targets in a perforin-dependent manner. Although IFN-γ is essential for antiviral protection, it can be produced by either secondary effectors or concomitant primary effector CD8(+) T cells recruited to the response. Thus, during lethal virus challenge, memory CD8(+) T cells are required for cytolytic killing of infected cells, but primary effectors can play important roles by producing IFN-γ.


Journal of Immunology | 2018

Cutting Edge: Protection by Antiviral Memory CD8 T Cells Requires Rapidly Produced Antigen in Large Amounts

Sanda Remakus; Xueying Ma; Lingjuan Tang; Ren-Huan Xu; Cory Knudson; Carolina R. Melo-Silva; Daniel Rubio; Yin-Ming Kuo; Andrew J. Andrews; Luis J. Sigal

Numerous attempts to produce antiviral vaccines by harnessing memory CD8 T cells have failed. A barrier to progress is that we do not know what makes an Ag a viable target of protective CD8 T cell memory. We found that in mice susceptible to lethal mousepox (the mouse homolog of human smallpox), a dendritic cell vaccine that induced memory CD8 T cells fully protected mice when the infecting virus produced Ag in large quantities and with rapid kinetics. Protection did not occur when the Ag was produced in low amounts, even with rapid kinetics, and protection was only partial when the Ag was produced in large quantities but with slow kinetics. Hence, the amount and timing of Ag expression appear to be key determinants of memory CD8 T cell antiviral protective immunity. These findings may have important implications for vaccine design.


Cell Reports | 2018

Migratory Dendritic Cells, Group 1 Innate Lymphoid Cells, and Inflammatory Monocytes Collaborate to Recruit NK Cells to the Virus-Infected Lymph Node

Eric Wong; Ren-Huan Xu; Daniel Rubio; Avital Lev; Colby Stotesbury; Min Fang; Luis J. Sigal

Circulating natural killer (NK) cells help protect the host from lympho-hematogenous acute viral diseases by rapidly entering draining lymph nodes (dLNs) to curb virus dissemination. Here, we identify a highly choreographed mechanism underlying this process. Using footpad infection with ectromelia virus, a pathogenic DNA virus of mice, we show that TLR9/MyD88 sensing induces NKG2D ligands in virus-infected, skin-derived migratory dendritic cells (mDCs) to induce production of IFN-γ by classical NK cells and other types of group 1 innate lymphoid cells (ILCs) already in dLNs, via NKG2D. Uninfected inflammatory monocytes, also recruited to dLNs by mDCs in a TLR9/MyD88-dependent manner, respond to IFN-γ by secreting CXCL9 for optimal CXCR3-dependent recruitment of circulating NK cells. This work unveils a TLR9/MyD88-dependent mechanism whereby in dLNs, three cell types-mDCs, group 1 ILCs (mostly NK cells), and inflammatory monocytes-coordinate the recruitment of protective circulating NK cells to dLNs.


Cell Host & Microbe | 2013

Crosstalk between the Type 1 Interferon and Nuclear Factor Kappa B Pathways Confers Resistance to a Lethal Virus Infection

Daniel Rubio; Ren-Huan Xu; Sanda Remakus; Trayce E. Krouse; M.E. Truckenmiller; Roshan J. Thapa; Siddharth Balachandran; Antonio Alcami; Christopher C. Norbury; Luis J. Sigal


Quaternary International | 2010

Technical and technological complexity in the beginning: The study of Dmanisi lithic assemblage

Javier Baena; David Lordkipanidze; Felipe Cuartero; Reid Ferring; David Zhvania; Diego Martín; Teona Shelia; Giorgi Bidzinashuili; Marta Roca; Daniel Rubio


Quaternary International | 2017

Late Middle Pleistocene genesis of Neanderthal technology in Western Europe: The case of Payre site (south-east France)

Javier Baena; Marie-Hélène Moncel; Felipe Cuartero; M. Gema Chacón Navarro; Daniel Rubio


Immunity | 2015

Sequential Activation of Two Pathogen-Sensing Pathways Required for Type I Interferon Expression and Resistance to an Acute DNA Virus Infection

Ren-Huan Xu; Eric Wong; Daniel Rubio; Felicia Roscoe; Xueying Ma; Savita Nair; Sanda Remakus; Reto A. Schwendener; Shinu John; Mark J. Shlomchik; Luis J. Sigal

Collaboration


Dive into the Daniel Rubio's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Ren-Huan Xu

Fox Chase Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xueying Ma

Fox Chase Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Felipe Cuartero

Autonomous University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Javier Baena

Autonomous University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Marta Roca

Autonomous University of Madrid

View shared research outputs
Top Co-Authors

Avatar

Avital Lev

Fox Chase Cancer Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eric Wong

Fox Chase Cancer Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge